FTC sues big pharmacy gain managers above insulin prices The agency introduced motion towards Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the record cost of daily life-preserving insulin medication.This program aligns with Individuals initiatives, the ON… Read More


Novo CEO pressed by Senate to chop costs of obesity, diabetes prescription drugs CEO Lars Fruergaard Jørgensen informed lawmakers the corporation would contemplate new talks with insurers about the checklist price ranges of Wegovy and copyright when they pledge to maintain the medicines on their own formularies.Pay attention to the post ten min Th… Read More


FTC sues key pharmacy benefit supervisors over insulin price ranges The agency brought action against Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the listing price of life-saving insulin prescription drugs.Insurers will continue on vertically integrating to ma… Read More